DOVATO (olutegravir/lamivudine) Patient Assistance Program

Don’t let the high cost of Dovato disrupt your HIV treatment. ViiV Healthcare’s patient assistance program provides Dovato free of charge to eligible patients — and we manage your entire enrollment for a flat $69.95 per month.

HIPAA Compliant

BBB Accredited

Secure Website

Key ​Takeaways:

What Is Dovato Prescription Assistance Program?

The Dovato Patient Assistance Program is run by ViiV Healthcare — the GSK-majority company focused entirely on HIV — through its ViiVConnect support hub, and provides Dovato at no cost to qualifying uninsured and underinsured patients, with income eligibility reaching approximately 500% of the Federal Poverty Level. Applying directly (1-844-588-3288, Mon–Fri 8 AM–11 PM ET) is always free. But HIV medication assistance has a layer most categories don’t: before or alongside a manufacturer program, many patients qualify for the federal Ryan White HIV/AIDS Program and their state’s AIDS Drug Assistance Program (ADAP), which can cover medications, insurance premiums, and copays. Sequencing these correctly — ADAP first where it applies, manufacturer programs where it doesn’t, savings cards for the commercially insured — is exactly the kind of navigation that determines whether treatment stays uninterrupted. For a flat $69.95 per month, our Patient Advocates handle every step, from program selection through renewals.

Pharmacy Price Comparison

Pharmacy(With Coupon)PrIce (30-Day)*You Save W/ Us
Walgreens

~$3,700.00

Save ~$3,630/mo

CVS Pharmacy

~$3,800.00

Save ~$3,730/mo

Walmart 

~$3,500.00

Save ~$3,430/mo

Costco

~$3,450.00

Save ~$3,380/mo

Kroger

~$3,500.00

Save ~$3,430/mo

*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.

Our Pricing:

$69.95 Per month

1 Medications

$79.95 Per Month

2 Medications

$89.95 Per Month

3 Medications

$99.95 Per Month

4+ Medications

Why choose us For Your Dovato Prescription Program?

The ViiVConnect assistance program is free to apply for and provides Dovato at no medication cost if approved. Our $69.95/month service covers full advocacy — for patients who want an experienced team managing the process end-to-end, including Ryan White/ADAP coordination alongside manufacturer programs.

Enroll

Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.

We Advocate

Our specialists help gather documentation, complete applications, and coordinate with program providers.

Receive Medication

Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.

Discount Coupons vs. Patient Assistance Programs

Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Dovato:

Limitations of Coupons

  • Prices fluctuate — savings aren’t guaranteed month-to-month
  • Copay accumulators may prevent savings from counting toward deductible
  • Coupon cards expire and require constant renewal
  •   Still $3,400–$3,800 per month even with the best discount

  • Can’t be used with Medicare, Medicaid, or government insurance
  •  

Advantages of PAP Through Us

  • Fixed $69.95/month — never changes regardless of retail price
  • No expiration — continuous access as long as you qualify
  • Medication supplied directly through the assistance program
  • We manage all paperwork, refills, and annual renewals
  • If denied, we explore alternative savings on your behalf

DO YOU QUALIFY?

ViiVConnect reviews eligibility based on insurance status and household income. You will generally qualify if the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Dovato assistance:

Not sure if you qualify?  Our pre-qualification check is completely free. If we can’t help, you won’t be charged.

Understanding Dovato:

Dovato combines dolutegravir (50 mg), an integrase strand transfer inhibitor, with lamivudine (300 mg), a nucleoside reverse transcriptase inhibitor, in a single once-daily tablet — a complete HIV-1 regimen built on two drugs instead of the traditional three.

How Dovato Works:

Dolutegravir blocks integrase, the enzyme HIV uses to insert its genetic material into your cells’ DNA; lamivudine blocks reverse transcriptase, the enzyme that copies viral RNA into DNA in the first place. Hitting both steps suppresses viral replication to undetectable levels in patients who take it consistently — and undetectable means untransmittable (U=U). The two-drug design reduces lifetime drug exposure without sacrificing suppression for eligible patients.

Form and Use:

One tablet, once daily, with or without food, as a complete regimen for adults with HIV-1 who have no known resistance to either component — either as a starting regimen or a switch for patients already virologically suppressed. Because consistency is everything in HIV treatment (missed doses invite resistance), affordability interruptions aren’t just a financial problem — they’re a clinical one. That’s the core reason assistance enrollment and renewal deadlines matter more here than in almost any other category.

Generic Availability:

There is no generic version of the Dovato combination tablet in the U.S. — patent protection on the dolutegravir component runs into the early 2030s. Lamivudine alone has long been generic, but the combination and dolutegravir itself remain brand-only, so there is no direct lower-cost substitute for the single-tablet regimen. Assistance programs, ADAP, and the Part D cap are the affordability levers.

Warnings:

Patients co-infected with hepatitis B need special management — lamivudine is active against HBV, and stopping Dovato can cause severe hepatitis B flares. Dolutegravir has been associated with hypersensitivity reactions and, rarely, liver problems; report rash, fever, or fatigue promptly. Tell your prescriber if you are pregnant or planning pregnancy, and review all medications — certain antacids, supplements, and the diabetes drug metformin interact with dolutegravir.

FAQ (Frequently Asked Questions)

How Much Does Dovato Cost Without Insurance?

ViiV’s published list price is $3,250.47 for a 30-day supply — about $39,000 per year. Eligible patients can receive Dovato free through the ViiVConnect Patient Assistance Program; our $69.95 monthly fee covers full advocacy and enrollment management.

Every state runs an AIDS Drug Assistance Program under the federal Ryan White Program, providing HIV medications — including Dovato in most state formularies — to low-income residents, and often paying insurance premiums and copays too. Income limits vary by state, and many patients who assume they earn too much actually qualify. Checking ADAP first is standard practice; we handle the screening as part of enrollment.

Yes — under Part D, and since the Part D redesign your total annual out-of-pocket for all covered drugs is capped ($2,100 in 2026), with the option to spread costs monthly through the Medicare Prescription Payment Plan. Manufacturer copay cards can’t be used with Medicare, but Extra Help and ADAP can both reduce what you owe.

If you have commercial insurance that covers Dovato, yes — as little as $0 per fill, up to $6,250 per year (or $7,500 combined across ViiV oral medicines). It cannot be used with any government insurance.

No — the combination tablet remains brand-only, with dolutegravir patents running into the early 2030s. No lower-cost direct substitute exists

Assistance programs are bound by the same privacy laws as the rest of your care. Applications go to the program administrator, not your employer or landlord. We handle your paperwork with strict confidentiality — a concern we take seriously because it stops many HIV patients from applying at all.

Denials are usually about documentation — missing income proof, an insurance-status mismatch, or incomplete prescriber sections. Applications can be corrected and resubmitted, and ADAP often remains a parallel path. We review the denial letter, fix what triggered it, and resubmit on your behalf.

Take Control of Your Medication Costs

If you are struggling with the high cost of Dovato, our team may be able to help you access assistance programs designed to make brand single-tablet HIV regimens affordable. Check your eligibility today.

Submit Enrollment Form

Start free by filling out a simple online form.

Receive Welcome Call

Our specialist will contact you for a quick welcome call.

We Manage The Process

Our team handles everything, so you can focus on your health.

Receive Welcome Call

We Manage The Process